Development of a formulation of Pirodavir using 2-hydroxypropyl-β- cyclodextrin

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 57, Issue 1-4, 2007, Pages 137-139

  Peeters, Jef ^a   Neeskens, Peter ^a   Brewster, Marcus Eli ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

Complexation capacity; Cyclodextrins; Nasal formulation; Pirodavir; Solubility

Indexed keywords

EID: 34047134926     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-006-9205-z     Document Type: Conference Paper

References (6)

1. Hayden F.G., Andries K., Janssen P.A.J.: Safety and efficacy of intranasal pirodavir (R77975) in experimental Rhinovirus infection. Antimicrob. Agents Chemother. 36, 727-732 (1992)
2. and Hayden F.G., Hipskind G.J., Woerner D.H., Eisen G.F., Janssen M., Janssen P.A.J., Andries K., Intranasal pirodavir (R77975) treatment of rhinovirus colds. Antimicrob. Agents Chemother. 39, 290-294 (1995)
3. Loftsson, T., Brewster, M.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017-1025 (1966)
4. Higuchi, T., Connors, K.A.: In: Reilly, C.N. (ed.) Advances in Analytical Chemistry and Instrumentation, vol. 4. New York: Wiley-Interscience, pp. 117-212 (1965)
5. Higuchi, T., Kristiansen, H.: Binding specificity between small organic solutes in aqueous solution: Classification of some solutes into two groups according to binding tendencies. J. Pharm. Sci 59, 1601-1608 (1970)
6. Merkus, F.W.H.M., Verhoef, J.C., Marttin, E., Romeijn, S.G., van der Kuy, P.H.M., Hermens, W.A.J.J., Schipper, N.G.M.: Cyclodextrins in nasal drug delivery, Adv. Drug Del. Rev 36, 41-57 (1999)